IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Nasdaq Biological Products, (No Diagnostic Substances) Accelerated filer

Key Financials

Revenue
$263.5M
↑ 60.6%
Net Income
$-390978000
↓ 5.1%
Operating Income
$-403356000
↓ 2.0%
Total Liabilities
$214.6M
↑ 7.3%
Cash & Equivalents
$163.1M
↑ 41.0%
EPS (Diluted)
$-1.09
↑ 14.8%
Total Assets
$913.2M
↑ 0.3%
Shareholders' Equity
$698.6M
↓ 1.7%

Recent SEC Filings

Form Type Filed Date Link
8-K 7/2/2026 View on SEC
4 6/18/2026 View on SEC
4 6/18/2026 View on SEC
4 6/18/2026 View on SEC
4 6/18/2026 View on SEC
4 6/18/2026 View on SEC
S-8 6/18/2026 View on SEC
S-8 6/18/2026 View on SEC
S-3ASR 6/18/2026 View on SEC
8-K 6/10/2026 View on SEC

Company Information

Field Value
Ticker IOVA
Company Name IOVANCE BIOTHERAPEUTICS, INC.
CIK 1425205
Sector Biological Products, (No Diagnostic Substances)
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 6502607120